Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE Inhibitors and Sacubitril-Valsartan for Cardiotoxicity Prevention in BMT
NCT04092309Unknown
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Sep 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sacubitril + valsartan in Cardiotoxicity, sponsored by National and Kapodistrian University of Athens. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT04092309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04092309.